Allergan wishes to extend their project portfolio in biopolymers for medical injectable and/or implantable applications through initiating new partnerships with academic or biotech partners.

Allergan is especially focused on structural proteins and biopolymers found in skin and soft tissues, such as:

  • Glycosaminoglycans (GAGs): hyaluronic acid, heparan sulfate, heparosan, dermatan sulfate, chitosan, chondroitin sulfate
  • Integrin extracellular ligands: collagen, elastin, polylysine, fibronectin, laminin, nidogens, osteopontin, …
  • Peptides: RGD peptides, Pal KTTKS, elastin-like peptide (ELP),…

Allergan is trying to identify projects related to such biopolymers and proteins for medical injectable and/or implantable applications.

They are looking for projects from preclinical stage (with an emphasis on in vivo projects) to recently marketed products.

If you believe that your organization could be a good fit, send a non-confidential summary of your work (slide deck preferred) to .

Find an actor

BioAlps Networking Day 201829.11.2018

L'événement aura lieu au SICHH le 29 novembre 2018 au blueFACTORY à Fribourg

AMAL Therapeutics raises 33.2 million dollars

The Geneva-based startup just announced the completion of its Series B financing round, raising in total CHF 33.2...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn